Inotropic therapy for cardiac low output syndrome: Comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine

European Journal of Medical Research

Volumn 13, Issue 10, 2008, Pages 459-463

  El Mokhtari, Nour Eddine ^a   Arlt, A ^a   Meissner, A ^a   Lins, M ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cardiogenic shock; Dobutamine; Dopamine; Dopexamine; Low cardiac output syndrome

Indexed keywords

DOBUTAMINE; DOPAMINE; DOPEXAMINE; INOTROPIC AGENT;

AGED; ANURIA; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FORWARD HEART FAILURE; HEART INDEX; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEMODIAFILTRATION; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MONOTHERAPY; OLIGURIA; PULMONARY ARTERY OCCLUSION PRESSURE; RETROSPECTIVE STUDY;

AGED; BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; DOBUTAMINE; DOPAMINE; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC;

EID: 56249126373     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Agency for Health Care Policy and Research (1998) Heart failure: evaluation and treatment of patient's with left ventricular systolic dysfunction. Agency for Health Care Policy and Research (AHCPR)]. J Am Geriatr Soc 46:525-529
2. Coodley E (1999) Newer drug therapy for congestive heart failure. Arch Intern Med 159:1177-1183
3. Stevenson LW (1998) Inotropic therapy for heart failure. N Engl J Med 339:1848-1850
4. Heart Failure Society of America (1999) Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches. J Card Fail 5:357-382
5. Schwertz H, Muller-Werdan U, Prondzinsky R, Werdan K, Buerke M (2004) [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?]. Dtsch Med Wochenschr 129:1925-1930
6. Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330:1724-1730
7. Sanborn TA, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, Wong SC, Boland J, Pfisterer M, Slater JN, Sharma S, Hochman JS (2003) Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol 42:1373-1379
8. Stevenson LW, Rose EA (2003) Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 108:3059-3063
9. Stevenson LW (2003) Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy. Circulation 108:492-497
10. Stevenson LW (2003) Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization. Circulation 108:367-372
11. Stephan H, Sonntag H, Henning H, Yoshimine K (1990) Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine. Br J Anaesth 65:380-387
12. Jones D, Bellomo R (2005) Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition? J Intensive Care Med 20:199-211
13. Holmes CL (2005) Vasoactive drugs in the intensive care unit. Curr Opin Crit Care 11:413-417
14. Lisbon A (2003) Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: what is the evidence? Chest 123:460S-463S
15. Thoren A, Elam M, Ricksten SE (2000) Differential effects of dopamine, dopexamine, and dobutamine on jejunal mucosal perfusion early after cardiac surgery. Crit Care Med 28:2338-2343
16. Neviere R, Mathieu D, Chagnon JL, Lebleu N, Wattel F (1996) The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 154:1684-1688
17. Stamatelopoulos S, Zakopoulos N, Saridakis N, Stefanou S, Adractas A, Kanakakis J, Vinieratos N, Zoumis G, Gougoulakis A, Moulopoulos S (1993) Catecholamine infusion versus intraaortic counterpulsation at the initial phase of left intraventricular balloon pumping in the fibrillating animal heart. Int J Artif Organs 16:86-90
18. Moulopoulos SD, Stamateolopoulos SF, Nanas JN, Kontoyannis DA, Nanas SN (1993) Effect of protracted dobutamine infusion on survival of patients in cardiogenic shock treated with intraaortic balloon pumping. Chest 103:248-252
19. Suga H, Hayashi T, Suehiro S, Hisano R, Shirahata M, Ninomiya I (1981) Equal oxygen consumption rates of isovolumic and ejecting contractions with equal systolic pressure-volume areas in canine left ventricle. Circ Res 49:1082-1091
20. Levy B, Nace L, Bollaert PE, Dousset B, Mallie JP, Larcan A (1999) Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock. Intensive Care Med 25:942-948
21. Rosseel PM, Santman FW, Bouter H, Dott CS (1997) Postcardiac surgery low cardiac output syndrome: dopexamine or dopamine? Intensive Care Med 23:962-968
22. Takala J, Meier-Hellmann A, Eddleston J, Hulstaert P, Sramek V (2000) Effect of dopexamine on outcome after major abdominal surgery: a prospective, randomized, controlled multicenter study. European Multicenter Study Group on Dopexamine in Major Abdominal Surgery. Crit Care Med 28:3417-3423
23. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC (1995) Increasing splanchnic blood flow in the critically III. Chest 108:1648-1654
24. Smithies M, Yee TH, Jackson L, Beale R, Bihari D (1994) Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med 22:789-795
25. Byers RJ, Eddleston JM, Pearson RC, Bigley G, McMahon RF (1999) Dopexamine reduces the incidence of acute inflammation in the gut mucosa after abdominal surgery in high-risk patients. Crit Care Med 27:1787-1793
26. Secchi A, Ortanderl JM, Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H (2001) Effects of dobutamine and dopexamine on hepatic micro- and macrocirculation during experimental endotoxemia: an intravital microscopic study in the rat. Crit Care Med 29:597-600
27. Hiltebrand LB, Krejci V, Sigurdsson GH (2004) Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 100:1188-1197
28. Hochmann JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. New Engl J Med 34:625-634
29. Meissner A, Schmelzle T, Simon R. (1996) Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/ dobutamine. Z Kardiol. 85(11):839-846
30. Meissner A, Herrmann G, Gerdesmeyer L, Simon R. (1992) Additive effects of milrinone and dobutamine in severe heart failure. Z Kardiol. 81(5):266-271